Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.52 USD | +8.15% | -0.40% | -40.14% |
Apr. 26 | UBS Cuts CureVac Price Target to $14 From $18, Maintains Buy Rating | MT |
Apr. 25 | Leerink Partners Downgrades CureVac to Market Perform From Outperform, Sets Price Target at $4 | MT |
Sales 2024 * | 71.1M 76.15M | Sales 2025 * | 99.07M 106M | Capitalization | 487M 522M |
---|---|---|---|---|---|
Net income 2024 * | -174M -186M | Net income 2025 * | -117M -125M | EV / Sales 2024 * | 5.42 x |
Net cash position 2024 * | 102M 109M | Net cash position 2025 * | 93.33M 99.96M | EV / Sales 2025 * | 3.97 x |
P/E ratio 2024 * |
-2.83
x | P/E ratio 2025 * |
-3.85
x | Employees | 977 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 54.57% |
Latest transcript on CureVac N.V.
1 day | +8.15% | ||
1 week | -0.40% | ||
Current month | -16.83% | ||
1 month | -16.83% | ||
3 months | -31.89% | ||
6 months | -51.07% | ||
Current year | -40.14% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 23-03-27 | |
Pierre Kemula
DFI | Director of Finance/CFO | 50 | 16-10-31 |
Malte Greune
COO | Chief Operating Officer | 59 | 21-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Tooman
BRD | Director/Board Member | 58 | 19-05-31 |
Michael Brosnan
BRD | Director/Board Member | 69 | 23-06-18 |
Director/Board Member | 67 | 22-06-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.74% | 17 M€ | -.--% | - | |
0.06% | 2 M€ | -.--% | ||
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 2.52 | +8.15% | 594,428 |
24-04-26 | 2.33 | +0.87% | 837,605 |
24-04-25 | 2.31 | -7.97% | 1,242,504 |
24-04-24 | 2.51 | -3.46% | 1,084,869 |
24-04-23 | 2.6 | +2.77% | 609,966 |
Delayed Quote Nasdaq, April 29, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.14% | 522M | |
+1.77% | 42.75B | |
+47.70% | 41.61B | |
+12.24% | 41.34B | |
-8.83% | 26.59B | |
+7.44% | 25.49B | |
-23.01% | 18.12B | |
+30.56% | 12.24B | |
-1.82% | 11.76B | |
+8.35% | 11B |
- Stock Market
- Equities
- CVAC Stock